Boule Diagnostics Valuation
| BOUL Stock | SEK 8.82 0.24 2.65% |
At this time, the firm appears to be overvalued. Boule Diagnostics shows a prevailing Real Value of kr7.56 per share. The current price of the firm is kr8.82. Our model approximates the value of Boule Diagnostics from analyzing the firm fundamentals such as Return On Equity of 0.0335, current valuation of 562.26 M, and Profit Margin of 0.02 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Boule Diagnostics' price fluctuation is slightly risky at this time. Calculation of the real value of Boule Diagnostics is based on 3 months time horizon. Increasing Boule Diagnostics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Boule Diagnostics' intrinsic value may or may not be the same as its current market price of 8.82, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.82 | Real 7.56 | Hype 8.82 | Naive 8.67 |
The intrinsic value of Boule Diagnostics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Boule Diagnostics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Boule Diagnostics AB helps investors to forecast how Boule stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Boule Diagnostics more accurately as focusing exclusively on Boule Diagnostics' fundamentals will not take into account other important factors: Boule Diagnostics Total Value Analysis
Boule Diagnostics AB is currently anticipated to have takeover price of 562.26 M with market capitalization of 532.01 M, debt of 50.6 M, and cash on hands of 38.18 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Boule Diagnostics fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
562.26 M | 532.01 M | 50.6 M | 38.18 M |
Boule Diagnostics Investor Information
About 13.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.06. Some equities with similar Price to Book (P/B) outperform the market in the long run. Boule Diagnostics last dividend was issued on the 6th of May 2022. The entity had 4:1 split on the 1st of June 2018. Based on the key indicators related to Boule Diagnostics' liquidity, profitability, solvency, and operating efficiency, Boule Diagnostics AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Boule Diagnostics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Boule Diagnostics has an asset utilization ratio of 81.0 percent. This implies that the Company is making kr0.81 for each dollar of assets. An increasing asset utilization means that Boule Diagnostics AB is more efficient with each dollar of assets it utilizes for everyday operations.Boule Diagnostics Ownership Allocation
Boule Diagnostics holds a total of 38.83 Million outstanding shares. Boule Diagnostics AB shows significant amount of outstanding shares owned by insiders and institutional investors .Since such a large part of the company is not owned by regular investors, we recommend to check if there were significant buying or selling the Boule Diagnostics AB stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Boule Diagnostics Profitability Analysis
The company reported the revenue of 463.34 M. Net Income was 23.27 M with profit before overhead, payroll, taxes, and interest of 227.9 M.About Boule Diagnostics Valuation
The stock valuation mechanism determines Boule Diagnostics' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Boule Diagnostics based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Boule Diagnostics. We calculate exposure to Boule Diagnostics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Boule Diagnostics's related companies.Boule Diagnostics AB , a diagnostics company, develops, manufactures, and markets instruments and consumable products for blood diagnostics. Boule Diagnostics AB was founded in 1956 and is headquartered in Spnga, Sweden. Boule Diagnostics operates under Image Processing classification in Sweden and is traded on Stockholm Stock Exchange.
8 Steps to conduct Boule Diagnostics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Boule Diagnostics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Boule Diagnostics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Boule Diagnostics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Boule Diagnostics' revenue streams: Identify Boule Diagnostics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Boule Diagnostics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Boule Diagnostics' growth potential: Evaluate Boule Diagnostics' management, business model, and growth potential.
- Determine Boule Diagnostics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Boule Diagnostics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Boule Stock Analysis
When running Boule Diagnostics' price analysis, check to measure Boule Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boule Diagnostics is operating at the current time. Most of Boule Diagnostics' value examination focuses on studying past and present price action to predict the probability of Boule Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boule Diagnostics' price. Additionally, you may evaluate how the addition of Boule Diagnostics to your portfolios can decrease your overall portfolio volatility.